These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunological aspects of psoriasis. I. Immunoglobulins and anti-IgG factors. Guilhou JJ; Clot J; Meynadier J; Lapinski H Br J Dermatol; 1976 May; 94(5):501-7. PubMed ID: 1083739 [TBL] [Abstract][Full Text] [Related]
4. [Letter: Change of serum immunoglobulins and salivary IgA in psoriasis]. Guilhou JJ; Meynadier J; Robinet-Levy M; Bascoul S Nouv Presse Med; 1973 Dec; 2(45):3047. PubMed ID: 4775193 [No Abstract] [Full Text] [Related]
5. [Study of the nature of antigammaglobulin factors by indirect fluorescent antibody technic]. Sany J; Clot J; Serre H Rev Rhum Mal Osteoartic; 1973 May; 40(5):313-8. PubMed ID: 4579367 [No Abstract] [Full Text] [Related]
6. [Histocompatibility antigens in psoriatic and seronegative rheumatoid arthritis]. Benevolenskaia LI; Erdes Sh; Iakovleva DB; Groppa LP Ter Arkh; 1986; 58(7):17-9. PubMed ID: 3764734 [TBL] [Abstract][Full Text] [Related]
7. HL-A antigens and some immunological parameters in psoriasis. Seignalet J; Clot J; Guilhou JJ; Duntze F; Meynadier J; Robinet-Levy M Tissue Antigens; 1974; 4(1):59-68. PubMed ID: 4209911 [No Abstract] [Full Text] [Related]
8. HL-A Antigens and lymphocytotoxic antibodies in psoriasis vulgaris. Stenszky V; Nagy E; Szerze P; Ladányi E Dermatol Monatsschr; 1976 Jan; 162(1):35-8. PubMed ID: 955181 [No Abstract] [Full Text] [Related]
10. [IgG type rheumatoid factor in inflammatory rheumatism]. Simplicio F; Lapadula G; Carrozzo M Reumatismo; 1975; 27(1):244-50. PubMed ID: 1085967 [No Abstract] [Full Text] [Related]
11. [Histocompatibility antigens (HL-A) in psoriasis. A study of 104 unrelated patients (author's transl)]. Schoefinius HH; Braun-Falco O; Scholz S; Steinbauer-Rosenthal I; Wank R; Albert ED Dtsch Med Wochenschr; 1974 Mar; 99(10):440-4. PubMed ID: 4471830 [No Abstract] [Full Text] [Related]
12. [Data on changes in serums and tissues and immunoglobulins in various dermatoses]. Butov IuS; Skripkin IuK; Koshevenko IuK; Stefani DV Vestn Dermatol Venerol; 1974 Oct; 0(10):8-15. PubMed ID: 4432623 [No Abstract] [Full Text] [Related]
13. Significance of serologic abnormalities in lepromatous leprosy. Malaviya AN; Pasricha A; Pasricha JS; Mehta JS Int J Lepr Other Mycobact Dis; 1972; 40(4):361-5. PubMed ID: 4202461 [No Abstract] [Full Text] [Related]
14. HL-A antigens in psoriatic arthritis. Karvonen J; Lassus A; Sievers U; Tiilikainen A Ann Clin Res; 1974 Oct; 6(5):304-7. PubMed ID: 4447342 [No Abstract] [Full Text] [Related]
16. [Physiopathology of rheumatoid psoriasis]. Sany J; Clot J; Seignalet J; Guilhou JJ; Serre H Rev Rhum Mal Osteoartic; 1979 Oct; 46(10):551-60. PubMed ID: 317533 [TBL] [Abstract][Full Text] [Related]
17. [Immunoglobulin levels in the serum of patients with psoriasis]. Placek W; Sztaba-Kania M; Jankowska-Gan E Przegl Dermatol; 1985; 72(6):507-11. PubMed ID: 3832159 [No Abstract] [Full Text] [Related]
18. Immunoglobulins and anti-immunoglobulin factors in psoriatic lesions. Krogh HK; Tönder O Clin Exp Immunol; 1972 Apr; 10(4):623-34. PubMed ID: 4556104 [TBL] [Abstract][Full Text] [Related]